伪膜性肠炎是一种主要发生于结肠和小肠的急性纤维素渗出性炎症,多系在应用抗生素后导致正常肠道菌群失调,难辨梭状芽胞杆菌大量繁殖,产生毒素而致病。因与抗生素的应用关系密切亦有“抗生素相关性肠炎”之称,该病多发生于老年人、重症患者、免疫功能低下及外科大手术后的患者,其临床表现轻重不一,可仅为轻度腹泻,也可出现高热、严重腹泻、水电解质紊乱、中毒性巨结肠,甚至危及生命。该病病情重,治疗不及时病死率高。由于广谱抗生素和免疫抑制剂的广泛应用,该病发病率有上升的趋势。
伪膜性肠炎 Pseudomembranous colitis ; pseudomembranous enterocolitis ; pseudomembranous enteritis ; PMC
伪膜性结肠炎 pseudomembranous colitis ; clostridium difficile colitis ; Colitis Pseudomembranous
相关性伪膜性肠炎 AAPMC
探讨伪膜性肠炎 pseudomembranous colitis ; PMC
可表现为伪膜性肠炎 pseudomembrannous colitis ; PMC
抗生素所致伪膜性肠炎 pseudrmembranous colitis ; PMC
致伪膜性肠炎 pseudomembranous colitis
的伪膜性肠炎 Pseudomembranous colitis
伪膜性大肠炎 Pseudomembranous colitis
性伪膜性结肠炎 Antibiotic associated pseudomembranous colitis
Clostridium difficile is one major causative agent of pseudomembranous colitis (PMC) and many cases of antibiotic-associated diarrhea in humans and animals. It has been reported that this organism produces at least two toxins, designated A (enterotoxin) and B (cytotoxin).
艰难梭菌(C.difficile)是人与动物伪膜性肠炎(PMC)和抗生素相关性腹泻的主要病原菌,该菌可产生至少2种毒素,A毒素为肠毒素,可导致肠道组织损伤、使家兔产生血性积液并具有纤维细胞毒性,B毒素对许多组织细胞都具有很强的毒性。
参考来源 - 艰难梭菌A毒素ELISA试剂盒的研制及微生态制剂对艰难梭菌感染的防治研究·2,447,543篇论文数据,部分数据来源于NoteExpress
目的:观察中西医结合治疗伪膜性肠炎的疗效。
Objective: To observe the effect of treating pseudomembranous colitis with integrated traditional Chinese and western medicine.
伪膜性肠炎常发生于应用抗生素之后,发病率有呈上升趋势。
Pseudomembranous colitis usually develops after antibiotics administration. The morbidity is gradually ascending.
方法:回顾性分析了16例伪膜性肠炎病例患者的用药及临床情况。
Method: The clinical data about therapeutic effects of 16 cases were retrospectively analysed.
应用推荐